Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01245348 · ClinicalTrials.gov registry record
Relative Effectiveness of Schizophrenia Therapy Study
A clinical trial, sponsored by Medco Health Solutions.
- Completed
- Registry status
- 1,110
- Enrollment target
NCT01245348: Completed study, sponsored by Medco Health Solutions.
NCT01245348 is a clinical trial that has completed, run by Medco Health Solutions. The registered enrollment target is 1,110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01245348 has completed, sponsored by Medco Health Solutions.
- COMPLETED
- Registry status
- 1,110 participants
- Enrollment target
Study Summary
The purpose of this study is to validate that SULT4A1-1 status stratification improves responses to atypical antipsychotics in schizophrenia and to extend these findings into bipolar disorder.
Interventions
- GENETIC SULT4A1-1 genetic test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,110 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-12 |
What the finished NCT01245348 record still lists
NCT01245348 is an observational study that tracks outcomes without assigning an intervention. Its 1,110 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which SULT4A1-1 genetic test is the first listed.
NCT01245348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01245348 about?
NCT01245348 is a clinical study titled "Relative Effectiveness of Schizophrenia Therapy Study". The purpose of this study is to validate that SULT4A1-1 status stratification improves responses to atypical antipsychotics in schizophrenia and to extend these findings into bipolar disorder.
What is the current status of trial NCT01245348?
This trial is currently completed. The enrollment target is 1,110 participants. The study started on 2010-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01245348?
The interventions under investigation include: SULT4A1-1 genetic test (GENETIC).
Who is sponsoring clinical trial NCT01245348?
This trial is sponsored by Medco Health Solutions, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia